DiscoverCore IM | Internal Medicine Podcast#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial
#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

Update: 2023-10-04
Share

Description

What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?

Sponsors: Post Investment: Real Estate Syndications || Hellofresh  

Show Notes & Transcript

  • 02:08 Framework for thinking about obesity
  • 03:42 History of obesity treatment
  • 06:29 Gila monsters and GLP and GIP mechanisms
  • 08:29 Story of how medications for diabetes were found to have a weight loss benefit
  • 12:50 SURMOUNT-1 trial


Tags: IMCore, CoreIM, primary care, cardiology, nurse practitioner, pharmacist, physician assistant



Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy
Comments 
loading
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

Core IM Team